Featured Research

from universities, journals, and other organizations

Cryptococcosis: New Recommendations Against Major Opportunistic Infection

Date:
February 9, 2007
Source:
CNRS
Summary:
Cryptococcosis ranks second among fatal opportunistic infections in patients infected by HIV and who are profoundly immunosuppressed. A multicentric prospective study, published in PLoS Medicine, was conducted in France by researchers from the Institut Pasteur and the CNRS among patients diagnosed with cryptococcosis. The study uncovers parameters associated with more severe infections, such as the patient's sex and the infecting serotype. In light of the results, the authors propose a modification in the therapeutic treatment of individuals suffering from cryptococcosis.

Cryptococcosis ranks second among fatal opportunistic infections in patients infected by HIV and who are profoundly immunosuppressed. A multicentric prospective study, published in PLoS Medicine, was conducted in France by researchers from the Institut Pasteur and the CNRS among patients diagnosed with cryptococcosis. The study uncovers parameters associated with more severe infections, such as the patient's sex and the infecting serotype. In light of the results, the authors propose a modification in the therapeutic treatment of individuals suffering from cryptococcosis.

Related Articles


Caused by a microscopic fungus, Cryptococcus neoformans, cryptococcosis affects immunosuppressed individuals, most of whom are infected by HIV, but who also suffer from other immunological disorders or who are receiving immunosuppressive treatments. Most often, the fungus causes meningoencephalitis, but the infection can also be localised in the lungs. The incidence of cryptococcosis in France has decreased by half with the availability of antiretroviral combination therapies, and now represents around 100 cases annually. However, in Africa and Asia, it remains the second most fatal opportunistic infection after tuberculosis in individuals infected by HIV, in some countries affecting up to 30% of them in the absence of access to antiretroviral drugs. It is now the first cause of meningitis among adults in Africa.

A vast cohort study was performed on patients diagnosed with cryptococcosis between 1997 and 2001 in France by Françoise Dromer, head of the Molecular Mycology unit (CNRS URA 3012) and National Reference Centre for Mycoses and Antifungals at the Institut Pasteur, and Olivier Lortholary, from the same Pasteur unit and the Necker-Pasteur Infectiology Centre, in collaboration with the French Cryptococcosis Study Group, which is composed of mycologists and clinicians in 77 centres throughout the territory.

Aiming to analyse the factors influencing the clinical presentation of the disease and its evolution (prognostic factors), this study enrolled 230 patients infected (HIV+) or not (HIV-) by HIV.

It demonstrates that the disease is more severe in men than women, suggesting influence of sex hormones. It is also more severe in HIV+ than in HIV- individuals. In terms of mortality, it is those patients suffering from a haematological malignancy (such as lymphoma or chronic leukaemia) in which cryptococcosis is the most serious. The study also demonstrates that between the two serotypes of C. neoformans present in France (A and D), serotype A is associated with a more severe presentation and evolution of the disease. Finally, the patients having neurological defects and/or abnormal consciousness, or abnormal neuroimaging at the time of diagnosis, have a worsened prognosis for survival.

Along with these different factors, the researchers studied the impact of the initial «fungal load» (the quantity of fungi in the organism) and the evolution of cryptococcosis according to the particular antifungal drugs used.

In light of all of the factors analysed, the authors advocate that all patients in whom a diagnosis of cryptococcosis has been established should have an assessment of their fungal load to evaluate the severity of the disease.

According to the researchers, this systematic assessment should include a cerebrospinal fluid culture, a blood culture, a urine culture, and a determination of the quantity (titration) of the circulating antigen of Cryptococcus.

«For patients who have a very high fungal load, we recommend starting an initial therapy combining two antifungals, a treatment that is currently only recommended in cases of meningitis and severe pneumonia», concludes Dromer.

The authors stress that the three-month mortality rate from cryptococcosis remains 15-20% in Western countries, and that this is much higher in Africa and Asia: this greatly justifies improving the therapeutic management of this disease in the future.


Story Source:

The above story is based on materials provided by CNRS. Note: Materials may be edited for content and length.


Cite This Page:

CNRS. "Cryptococcosis: New Recommendations Against Major Opportunistic Infection." ScienceDaily. ScienceDaily, 9 February 2007. <www.sciencedaily.com/releases/2007/02/070208100659.htm>.
CNRS. (2007, February 9). Cryptococcosis: New Recommendations Against Major Opportunistic Infection. ScienceDaily. Retrieved March 5, 2015 from www.sciencedaily.com/releases/2007/02/070208100659.htm
CNRS. "Cryptococcosis: New Recommendations Against Major Opportunistic Infection." ScienceDaily. www.sciencedaily.com/releases/2007/02/070208100659.htm (accessed March 5, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, March 5, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) — Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) — Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) — AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Adults Only Get The Flu Twice A Decade, Researchers Say

Adults Only Get The Flu Twice A Decade, Researchers Say

Newsy (Mar. 4, 2015) — Researchers found adults only get the flu about once every five years. Scientists analyzed how a person&apos;s immunity builds up over time as well. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins